1. Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer. (April 2017) Authors: Franken, M.D.; van Rooijen, E.M.; May, A.M.; Koffijberg, H.; van Tinteren, H.; Mol, L.; ten Tije, A.J.; Creemers, G.J.; van der Velden, A.M.T.; Tanis, B.C.; Uyl-de Groot, C.A.; Punt, C.J.A.; Koopman, M.; van Oijen, M.G.H. Journal: European journal of cancer Issue: Volume 75(2017) Page Start: 204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗